with almost 1.5 billion closures produced annually and a large portfolio of more than 230 references, gcs is a leading manufacturer of child resistant closures, tamper evident closures, dosing devices and droppers in europe. gcs provides standard as well as bespoke closure solutions for pharmaceutical applications to many of the major companies in the otc and ethical sectors in more than 60 countries. after unveiling its new iso 7 cleanroom in october 2014 &ndash the third for the group in astra plastique, gcs plant in france, gcs has achieved the iso 15378 certification gmp pharma. gcs has recently designed new product lines, such as capepharma®, a one piece tamper evident closure, pharmasafe&trade, a latest generation 2 piece child resistant closure and mediloc® pp24, a new size tamper evident crc. gcs is also developing new innovative concepts such as fliploc, a single piece crc for pills, powders or liquids, liteloc, a light weight crc, or cyrano, a biinjected tpe perfusion bottle closure&hellip gcs will present its unique expertise and its latest innovations for a broad range of products, including medical devices. meet gcs sales and r&d teams and talk with us about your new product development needs we look forward to seeing you about global closure systemswith a consolidated revenue of &euro583 million in 2013 and approximately 3 500 employees, global closure systems is one of the world&rsquos largest providers of closure solutions for the fmcg market. thanks to its 21 production sites strategically located in 13 countries all around the world gcs manufactures close to 40 billion plastic and metal closures per annum. gcs offers over 2 000 designs of standard and custom closures and dispensing systems for the global beverage, food,health care, household & industry, personal care, and wine & spirits markets. 
